Hyperketonemia (ketosis), oxidative stress and type 1 diabetes

Pathophysiology

Volumn 13, Issue 3, 2006, Pages 163-170

  Jain, Sushil K ^a   McVie, Robert ^a   Bocchini Jr , Joseph A ^a  

^a Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

Acetoacetate; Diabetes; Hyperketonemia; Ketosis; Oxygen radicals

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETOACETIC ACID; GLUTATHIONE; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; KETONE BODY; OXYGEN RADICAL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

AFRICAN AMERICAN; AUTOOXIDATION; BLOOD LEVEL; CELL CULTURE; DISEASE ASSOCIATION; GENE CONTROL; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCATION; HUMAN; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; KETOACIDOSIS; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; STREPTOZOCIN DIABETES; VASCULAR DISEASE;

EID: 33745685302     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pathophys.2006.05.005     Document Type: Review

References (75)

1. Rader D.J. Inflammatory markers of coronary risk. N. Engl. J. Med. 343 (2000) 1179-1182
2. Devaraj S., and Jialal I. Antioxidants and vitamins to reduce cardiovascular disease. Curr. Atheroscler. Rep. 2 (2000) 342-351
3. Koya D., and King G.L. Protein kinase C activation and the development of diabetic complications. Diabetes 47 (1998) 859-866
4. Keane S., Gallagher A., Ackroyd S., McShane M.A., and Edge J.A. Cerebral venous thrombosis during diabetic ketoacidosis. Arch. Dis. Childhood 86 (2002) 204-206
5. Iori E., Calo L., Valbusa D., et al. Diabetic ketosis activates lymphomonocyte-inducible nitric oxide synthase. Diab. Med. 19 (2002) 777-783
6. Jain S.K., and McVie R. Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients. Diabetes 48 (1999) 555-1850
7. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N. Engl. J. Med. 329 (1993) 977-986
8. Giugliano D., Ceriollo A., and Paolisso G. Oxidative stress and diabetic vascular complications. Diab. Care 19 (1996) 257-267
9. Dominguez C., Rutz E., Gussinye M., and Carrascosa A. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diab. Care 21 (1998) 1736-1742
10. Jain S.K., McVie R., Duett J., and Herbst J.J. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 38 (1989) 1539-1543
11. Santini S.A., Marra G., Giardina B., Cotroneo P., Mordente A., Martorana G.E., Manto A., and Ghirlanda G. Defective plasma antioxidant defences and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes 46 (1997) 1853-1858
12. Laaksonen D.E., Atalay M., Niskanen L., Uusitupa M., Hanninen O., and Sen C.K. Increased resting and exercise-induced oxidative stress in young IDDM men. Diab. Care 19 (1996) 569-574
13. Jain S.K. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragiliy in human red blood cells. J. Biol. Chem. 264 (1989) 21340-21345
14. Rajeswari P., Natarajan R., Nadler J.L., and Kumar D. Glucose induces lipid peroxidation and inactivation of membrane associated iron transport enzymes in human erythrocytes in vivo and in vitro. J. Cell. Physiol. 149 (1991) 100-109
15. Marshall S.M., Walker M., and Alberti K.G.M.M. Diabetic ketoacidosis and hyperglycaemic non-ketotic coma. In: Alberti K.G.M.M., DeFronzo R.A., Keen H., and Zimmet P. (Eds). International Textbook of Diabetes Mellitus (1992), John Wiley and Sons, New York 1151-1166
16. Adrogue H.J., Wilson H., Boyd III A.E., Suki W.N., and Eknoyan G. Plasma acid-base patterns in diabetic ketoacidosis. N. Engl. J. Med. 307 (1982) 1603-1610
17. Stephens J.M., Sulway M.J., and Watkins P.J. Relationship of blood acetoacetate and 3-hydroxybutyrate in diabetes. Diabetes 20 (1971) 485-489
18. Laffel L. Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diab. Metab. Res. Rev. 15 (1999) 412-426
19. Candiloros H., Muller S., Zeghari N., Donner M., Drouin P., and Ziegler O. Decreased erythrocyte membrane fluidity in poorly controlled IDDM. Influence of ketone bodies. Diab. Care 18 (1995) 549-551
20. Krane E.J. Diabetic ketoacidosis. Pediatr. Clin. N. Am. 34 (1987) 935-960
21. Brenner Z.R. Management of hyperglycemic emergencies. AACN Clin. Issues 17 (2006) 56-65
22. Yared Z., and Chiasson J.I. Ketoacidosis and hyperosmolar hyperglycemic state in adult diabetic patients. Minerva Med. 94 (2003) 909-913
23. Newton C.A., and Raskin P. Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus. Arch. Intern. Med. 164 (2004) 1925-1931
24. Umpierrez G.E., and Kitabchi A.E. Diabetic ketoacidosis: risk factors and management. Treat. Endocrinol. 3 (2003) 95-108
25. Sato Y., Hotta N., Sakamoto N., Matosuoka S., Ohishi N., and Yagi K. Lipid peroxide level in plasma of diabetic patients. Biochem. Med. 21 (1979) 104-107
26. Jain S.K., Levine S.N., and Duett J. Hollier B: elevated lipid peroxidation levels in red blood cells of streptozotocin-treated diabetic rats. Metabolism 39 (1989) 971-975
27. Mullarkey C.J., Eldstein D., and Brownlee M. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem. Biophys. Res. Commun. 173 (1990) 932-939
28. A. van Campenhout, C. van Campenhout, A.R. Lagrou, et al., Impact of diabetes mellitus on the relationship between iron-, inflammatory and oxidative stress, Diab. Metab. Res. Rev., in press.
29. Vlassara H. The AGE-receptor in the pathogenesis of diabetic complications. Diab. Metab. Res. Rev. 17 (2001) 436-443
30. Stern D., Yan S.D., Yan S.F., and Schmidt A.M. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv. Drug Deliv. Rev. 54 (2002) 1615-1625
31. Arai K., Maguchi S., Fuji S., Ishibash H., Oikawa K., and Taniguchi N. Glycation and inactivation of human Cu-Zn-superoxide dismutase. Identification of the in vitro glycated sites. J. Biol. Chem. 262 (1987) 16969-16972
32. Natarajan R., Gerrity R.G., Gu J.L., Lanting L., Thomas L., and Nadler J.L. Role of 12-lipoxygenase and oxidant stress in hyperglycaemia-induced acceleration of atherosclerosis in a diabetic pig model. Diabetologia 45 (2002) 125-133
33. Hsu R.M., Devaraj S., and Jialal I. Autoantibodies to oxidized low-density lipoprotein in patients with type 2 diabetes mellitus. Clin. Chim. Acta 317 (2002) 145-150
34. Nishikawa T., Edelstein D., Du X.L., Yamagishi S., Matsumura T., Kaneda Y., Yorek M.A., Beebe D., Oates P.J., Hammes H.P., Giardino I., and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage. Nature 404 (2000) 787-790
35. Tesfamariam B., and Cohen R.A. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am. J. Physiol. 262 (1992) H321-H326
36. Kitabchi A.E., Stentz F.B., and Umpierrez G.E. Diabetic ketoacidosis induces in vivo activation of human T-lymphocytes. Biochem. Biophys. Res. Commun. 315 (2004) 404-407
37. Jain S.K., McVie R., and Jaramillo J.J. Hyperketonemia (acetoacetate) increases the oxidizability of LDL + VLDL in type-i diabetic patients. Free Radic. Biol. Med. 24 (1998) 175-181
38. Jain S.K., McVie R., Jackson R., Levine S.N., and Lim G. Effect of hyperketonemia on lipid peroxidation levels of plasma in diabetic patients. Diab. Care 22 (1999) 1171-1175
39. Jain S.K., Kannan K., Lim G., Matthew-Greer J., McVie R., and Bocchini J.A. Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes. Diab. Care 26 (2003) 2139-2143
40. Jain S.K., and McVie R. Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type-1 diabetic patients. Diabetes 48 (1999) 1850
41. Jain S.K., Kannan K., and Lim G. Ketosis (acetoacetate) can generate oxygen radicals and cause increased lipid peroxidation and growth inhibition in human endothelial cells. Free Radic. Biol. Med. 25 (1998) 1083-1088
42. Jain S.K., Kannan K., and McVie R. Effect of hyperketonemia on blood monocyttes in type-1 diabetic patients and apoptosis in cultured U937 monocytes. Antioxid. Redox Signal. 1 (1999) 211
43. Kelly J. Making sense of free radicals and their effects on the body. Nurs. Times 90 (1994) 34-36
44. Jain S.K. The accumulation of malonyldialdehyde, a product of fatty acid peroxidation, can disturb aminophospholipid organization in the membrane bilayer of human erythrocytes. J. Biol. Chem. 259 (1984) 3391
45. Jain S.K. In vivo externalization of phosphatidylserine and phosphatidylethanolamine in the membrane bilayer and hypercoagulability by the lipid peroxidation of erythrocytes in rats. J. Clin. Invest. 76 (1985) 281
46. Rattan V., Sultana C., Shen Y., and Kalra V.K. Oxidant stress-induced transendothelial migration of monocytes is linked to phosphorylation of PECAM-1. Am. J. Physiol. 273 (1997) E453
47. Jain S.K., Mohandas N., Clark M.R., and Shohet S.B. The effect of malonyldialdehyde, a product of lipid peroxidation, on the deformability, dehydration, and 51Cr-survival of erythrocytes. Br. J. Haematol. 53 (1983) 247
48. Jain S.K., Morshed K.M., Kannan K., McMartin K.E., and Bocchini J.A. Effect of elevated glucose concentrations on cellular lipid peroxidation and growth of cultured human kidney proximal tubule cells. Mol. Cell. Biochem. 162 (1996) 11
49. Rattan V., Shen Y., Sultana C., Kumar D., and Kalra V.K. Diabetic RBC-induced oxidant stress leads to transendothelial migration of monocyte-like HL60 cells. Am. J. Physiol. 273 (1997) E369
50. Wali R.K., Jafe S., Kumar D., Sorgenete N., and Kalra V.K. Increased adherence of oxidanttreated human and bovine erythrocytes to cultured endothelial cells. J. Cell. Physiol. 133 (1987) 25
51. Banki R., Hutter E., Gonchoroff N.J., and Perl A. Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently form activation of caspases in fas signalling. J. Immunol. 162 (1999) 1466
52. Jain S.K., Ross J.D., and Levy G. The effect of malonyldialdehyde on viscosity of normal and sickle red blood cells. Biochem. Med. Metab. Biol. 44 (1990) 37-41
53. Li N., and Karin M. Is NF-kB the sensor of oxidative stress. FASEB J. 13 (1999) 1137-1143
54. Carl G.F., Hofffman W.H., Passmore G.G., Truemper E.J., Lightsey A.L., Cornwell P.E., and Jonal M.H. Diabetic ketoacidosis promotes a prothrombotic state. Endocr. Res. 29 (2003) 73-82
55. Hoffman W.H., Cheng C., Passmore G.G., Carroll J.E., and Hess D. Acetoacetate increases expression of intracellular adhesion molecule-1 (ICAM-1) in human brain microvascular endothelial cells. Neurosci. Lett. 334 (2002) 71
56. Uehara Y., Engel T., Li Z., et al. Polyunsaturated fatty acids and acetoacetate downregulate the expression of the ATP-binding cassette transporter A1. Diabetes 51 (2002) 2922-2928
57. Yokoo, et al. Distinct effect of ketones bodies on down-regulation of cell surface insulin receptor and insulin receptor substrate-1 phosphorylation in adrenal chromaffin cells. J. Pharmacol. Exp. Ther. 304 (2003) 995-1002
58. *. Methods Enzymol. 105 (1984) 209-215
59. Boveris A. Mitochondrial production of superoxide radical and hydrogen peroxide. Adv. Exp. Biol. Med. 78 (1977) 67-82
60. Guha M., Bai W., Nadler J.L., and Natarajan R. Molecular mechanisms of tumor necrosis factor a gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J. Biol. Chem. 275 (2000) 17728-17739
61. Stenz F.B., Umpierrez G.E., Cuervo R., and Kitabachi A.E. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes 53 (2004) 2079-2086
62. Yerneni K.K., Bai W., Khan B.V., Medford R.M., and Natarajan R. Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes 48 (1999) 855-864
63. Reddy M.A., Thimmalapura P.R., Lanting L., Nadler J.L., Fatima S., and Natarajan R. The oxidized lipid and lipoxygenase product 12(S)-hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation. Mediation of angiotensin II effects. J. Biol. Chem. 277 (2002) 9920-9928
64. Natarajan R., Gonzales N., Xu L., and Nadler J.L. Vascular smooth muscle cells exhibit increased growth in response to elevated glucose. Biochem. Biophys. Res. Commun. 187 (1992) 552-560
65. Natarajan R., Reddy M.A., Malik K.U., Fatima S., and Khan B.V. Signaling mechanisms of nuclear factor-kappab-mediated activation of inflammatory genes by 13-hydroperoxyoctadecadienoic acid in cultured vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1408-1413
66. Bharti A.C., and Aggrawal B.B. Nuclear factor-kappa B and cancer: its role in the prevention and therapy. Biochem. Pharmacol. 64 (2002) 883-888
67. Shanmugam N., Gaw Gonzalo I.T., and Natarajan R. Molecular mechanisms of high glucose-induced cyclooxygenase-2 expression in monocytes. Diabetes 53 (2004) 795-802
68. Jain S.K., Kannan K., Lim G., McVie R., and Bocchini J.A. Hyperketonemia increases TNF-α secretion in cultured U937 monocytes and type-1 diabetic patients. Diabetes 51 (2002) 2287-2293
69. Hoffman W.H., Burek C.L., Waller J.L., Fisher L.E., Khichi M., and Mellick L.B. Cytokine response to diabetic ketoacidosis and its treatment. Clin. Immunol. 108 (2003) 175-181
70. Dalton R.R., Hoffman W.H., Passmore G.G., and Martin S.L. Plasma C-reactive protein levels in severe diabetic ketoacidosis. Ann. Clin. Lab. Sci. 33 (2003) 435-442
71. Abdelmegeed M.A., Kim S.K., Woodcroft K.J., and Novak R.F. Acetoacetate activation of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in primary cultured rat hepatocytes: role of oxidative stress. J. Pharmacol. Exp. Ther. 310 (2004) 728-736
72. Schernthaner G.H., and Schernthaner G. Insulin resistance and inflammation in the early phase of type 2 diabetes: potential for therapeutic intervention. Scand. J. Clin. Lab. Invest. (Suppl.) 240 (2005) 30-40
73. Kim J.A., Berliner J.A., Natarajan R.D., and Nadler J.L. Evidence that glucose increases monocyte binding to human aortic endothelial cells. Diabetes 43 (1994) 1103-1107
74. Ming W.F., Bersani L., and Mantovani A. Tumor necrosis factor-álpha is chemotactic for monocytes and polymorphonuclear leukocytes. J. Immunol. 138 (1987) 1469-1474
75. Granger D.N., Vowinkel T., and Petnehazy T. Modulation of inflammatory response in cardiovascular disease. Hypertension 43 (2004) 924-931